This startup just used A.I. to dramatically reduce the time needed to find a potential new drug for a rare lung disease
Insilico Medicine discovered a completely new drug for pulmonary fibrosis and brought it to the cusp of clinical trials in just 18 months and at a cost of less than $2.7 million, a fraction of what it normally takes.
